Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine

  title={Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine},
  author={Tim Sobolevsky and Grigory M Rodchenkov},
  journal={The Journal of Steroid Biochemistry and Molecular Biology},

Figures and Tables from this paper

Mass spectrometric description of novel oxymetholone and desoxymethyltestosterone metabolites identified in human urine and their importance for doping control.

It is suggested that 18-nor-2ξ,17β-hydroxymethyl-17α-methyl-5α-androst-13-en-3α-diol is an important marker of oxymetholone abuse and better detectability could be achieved if 18-Nor-17,17-dimethyl-5 α- androst- 13-eni-3 α- diol is monitored.

Long-term detection of dehydrochloromethyltestosterone : one-year experience

After more than one year experience in the screening for recently reported dehydrochloromethyltestosterone (DHCMT) metabolites in our laboratory, it was demonstrated that the most long-term is a

Unambiguous identification and characterization of a long-term human metabolite of dehydrochloromethyltestosterone.

The structure of a long-term metabolite of dehydrochloromethyltestosterone (DHCMT) was elucidated and 8 possible metabolites with a 17α-methyl-17β-hydroxymethyl - structures were synthesized and compared to a major DHCMT long- term metabolite detected in reference urine excretion samples.

Alternative Markers for Methylnortestosterone Misuse in Human Urine.

A direct detection of methylnortestosterone sulfo-conjugated metabolites after ethyl acetate extraction and analysis by LC/Q/TOF-MS in negative ionization mode was performed, detecting two main sulfate metabolites (S1, S2).

Detection of Oral-Turinabol Metabolites by LC / MS Q-TOF

Oral-Turinabol, dehydrochloromethyltestosterone (DHCMT), is a synthetic anabolic androgenic steroid (AAS) prohibited in sports by the World Anti-Doping Agency. We used accurate-mass measurements by

Synthesis, characterization, and detection of new oxandrolone metabolites as long-term markers in sports drug testing

The studied specimens demonstrated significantly longer detection periods (up to 18 days) for the new oxandrolone metabolites compared to commonly targeted metabolites such as epiox androlone or 18-nor-oxandrolones, presenting a promising approach to improve the fight against doping.

New oxymesterone metabolites in human by gas chromatography-tandem mass spectrometry and their application for doping control.

Based on the behavior of the MS/MS results of product ion and precursor ion modes, a GC-MS/MS method has been developed monitoring these metabolites and can extend the detection window up to 4 days since the parent steroid was not detectable.

Urinary detection of conjugated and unconjugated anabolic steroids by dilute-and-shoot liquid chromatography-high resolution mass spectrometry.

A comprehensive detection of anabolic androgenic steroids metabolites is described using a 2-fold dilution of urine and subsequent analysis by liquid chromatography-high resolution mass spectrometry (LC-HRMS).

Sulfate metabolites as alternative markers for the detection of 4-chlorometandienone misuse in doping control.

Evaluated sulfate fraction of 4Cl-MTD metabolism by liquid chromatography-tandem mass spectrometry to establish potential long-term metabolites valuable for doping control purposes showed that five out of the six identified sulfate metabolites were detected in urine up to the last collected samples from both excretion studies.



Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.

A new metabolite generated from metandienone has been identified as 18-nor-17beta-hydroxymethyl,17alpha-methyl-androst-1,4,13-trien-3-one in excretion study urine samples providing a valuable tool for the long-term detection of metandiensone abuse by athletes in sports drug testing.

GC and capillary column GC/MS determination of synthetic anabolic steroids. II. 4-chloro-methandienone (oral turinabol) and its metabolites.

The determination of oral turinabol (4-chloro-17 alpha-methyl-17 beta-hydroxy-1,4-androstadien-3-one) [1] in the 'free' fraction of human urine samples by gas chromatography and capillary column gas

Metabolism of anabolic steroids in humans: synthesis of 6 beta-hydroxy metabolites of 4-chloro-1,2-dehydro-17 alpha-methyltestosterone, fluoxymesterone, and metandienone.

Human excretion studies showed that 6 beta-hydroxylation is the major metabolic pathway in the metabolism of 4-chloro-1,2-dehydro-17 alpha-methyltestosterone, fluoxymesterone, and metandienone, whereas for boldenone, 17 alpha-nakedosterone, and testosterone, 6 alpha-hydroxyation is negligible.

17-Epimerization of 17 alpha-methyl anabolic steroids in humans: metabolism and synthesis of 17 alpha-hydroxy-17 beta-methyl steroids.

It is shown that the extent of 17-epimerization depends on the A-ring structure and shows a great variation for the different 17 alpha-methyl anabolic steroids.

Detection of the misuse of steroids in doping control

Metabolism of anabolic androgenic steroids.

A review of the metabolism of AAS is presented and Testosterone is the principal androgenic steroid and its metabolism is compared with that of Aas.